Cargando…

Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk

BACKGROUND: Many patients at high cardiovascular risk do not reach targets for low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP). Depression is a frequent comorbidity in these patients and contributes to poor medication adherence. OBJECTIVE: The aim of this study was to elucidate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Katzmann, Julius L, Mahfoud, Felix, Böhm, Michael, Schulz, Martin, Laufs, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302826/
https://www.ncbi.nlm.nih.gov/pubmed/30587940
http://dx.doi.org/10.2147/PPA.S182765
_version_ 1783382059722473472
author Katzmann, Julius L
Mahfoud, Felix
Böhm, Michael
Schulz, Martin
Laufs, Ulrich
author_facet Katzmann, Julius L
Mahfoud, Felix
Böhm, Michael
Schulz, Martin
Laufs, Ulrich
author_sort Katzmann, Julius L
collection PubMed
description BACKGROUND: Many patients at high cardiovascular risk do not reach targets for low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP). Depression is a frequent comorbidity in these patients and contributes to poor medication adherence. OBJECTIVE: The aim of this study was to elucidate the associations between adherence to lipid-and BP-lowering drugs, the diagnosis of depression, and the control of LDL-C and BP. PATIENTS AND METHODS: This study was conducted as multicenter, single-visit cross-sectional study in Germany. Adherence was assessed by the Morisky Medication Adherence Scale-8 (MMAS-8), and depression was assessed as documented in the patient chart. RESULTS: A total of 3,188 ambulatory patients with hypercholesterolemia (39.8%), stable coronary artery disease (CAD; 7.4%), or both (52.9%) were included. Patients had a history of myocardial infarction (30.8%), diabetes (42.0%), were smokers (19.7%), and 16.1% had the investigator-reported diagnosis of depression. High or moderate adherence to lipid-lowering medication compared to low adherence was associated with lower LDL-C levels (105.5±38.3 vs 120.8±42.4 mg/dL) and lower BP (systolic BP 133.4±14.5 vs 137.9±13.9 mmHg, diastolic BP 78.3±9.6 vs 81.8±9.6 mmHg) and with a higher proportion of patients achieving the guideline-recommended LDL-C (16.9% vs 10.1%) and BP target (52.2% vs 40.8%, all comparisons P<0.0001). Adherence was worse in patients with depression. Correspondingly, patients with depression showed higher LDL-C levels, higher BP, and a lower probability of achieving the LDL-C and BP goal. Medication adherence correlated between BP- and lipid-lowering medications. CONCLUSION: Self-reported medication adherence can be easily obtained in daily practice. A low adherence and the diagnosis of depression identify patients at risk for uncontrolled LDL-C and BP who likely benefit from intensified care.
format Online
Article
Text
id pubmed-6302826
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63028262018-12-26 Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk Katzmann, Julius L Mahfoud, Felix Böhm, Michael Schulz, Martin Laufs, Ulrich Patient Prefer Adherence Original Research BACKGROUND: Many patients at high cardiovascular risk do not reach targets for low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP). Depression is a frequent comorbidity in these patients and contributes to poor medication adherence. OBJECTIVE: The aim of this study was to elucidate the associations between adherence to lipid-and BP-lowering drugs, the diagnosis of depression, and the control of LDL-C and BP. PATIENTS AND METHODS: This study was conducted as multicenter, single-visit cross-sectional study in Germany. Adherence was assessed by the Morisky Medication Adherence Scale-8 (MMAS-8), and depression was assessed as documented in the patient chart. RESULTS: A total of 3,188 ambulatory patients with hypercholesterolemia (39.8%), stable coronary artery disease (CAD; 7.4%), or both (52.9%) were included. Patients had a history of myocardial infarction (30.8%), diabetes (42.0%), were smokers (19.7%), and 16.1% had the investigator-reported diagnosis of depression. High or moderate adherence to lipid-lowering medication compared to low adherence was associated with lower LDL-C levels (105.5±38.3 vs 120.8±42.4 mg/dL) and lower BP (systolic BP 133.4±14.5 vs 137.9±13.9 mmHg, diastolic BP 78.3±9.6 vs 81.8±9.6 mmHg) and with a higher proportion of patients achieving the guideline-recommended LDL-C (16.9% vs 10.1%) and BP target (52.2% vs 40.8%, all comparisons P<0.0001). Adherence was worse in patients with depression. Correspondingly, patients with depression showed higher LDL-C levels, higher BP, and a lower probability of achieving the LDL-C and BP goal. Medication adherence correlated between BP- and lipid-lowering medications. CONCLUSION: Self-reported medication adherence can be easily obtained in daily practice. A low adherence and the diagnosis of depression identify patients at risk for uncontrolled LDL-C and BP who likely benefit from intensified care. Dove Medical Press 2018-12-18 /pmc/articles/PMC6302826/ /pubmed/30587940 http://dx.doi.org/10.2147/PPA.S182765 Text en © 2019 Katzmann et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Katzmann, Julius L
Mahfoud, Felix
Böhm, Michael
Schulz, Martin
Laufs, Ulrich
Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk
title Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk
title_full Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk
title_fullStr Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk
title_full_unstemmed Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk
title_short Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk
title_sort association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302826/
https://www.ncbi.nlm.nih.gov/pubmed/30587940
http://dx.doi.org/10.2147/PPA.S182765
work_keys_str_mv AT katzmannjuliusl associationofmedicationadherenceanddepressionwiththecontroloflowdensitylipoproteincholesterolandbloodpressureinpatientsathighcardiovascularrisk
AT mahfoudfelix associationofmedicationadherenceanddepressionwiththecontroloflowdensitylipoproteincholesterolandbloodpressureinpatientsathighcardiovascularrisk
AT bohmmichael associationofmedicationadherenceanddepressionwiththecontroloflowdensitylipoproteincholesterolandbloodpressureinpatientsathighcardiovascularrisk
AT schulzmartin associationofmedicationadherenceanddepressionwiththecontroloflowdensitylipoproteincholesterolandbloodpressureinpatientsathighcardiovascularrisk
AT laufsulrich associationofmedicationadherenceanddepressionwiththecontroloflowdensitylipoproteincholesterolandbloodpressureinpatientsathighcardiovascularrisk